Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
T-Cell Immunotherapy market report explains the definition, types, applications, major countries, and major players of the T-Cell Immunotherapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Novartis
Takara Bio
Kite Pharma
Unum Therapeutics
Juno Therapeutics
Cellectis
Adaptimmune
Altor Bioscience Corporation
By Type:
CAR-T
TCR
TIL Therapies
By End-User:
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global T-Cell Immunotherapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 T-Cell Immunotherapy Outlook to 2028- Original Forecasts
-
2.2 T-Cell Immunotherapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term T-Cell Immunotherapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global T-Cell Immunotherapy Market- Recent Developments
-
6.1 T-Cell Immunotherapy Market News and Developments
-
6.2 T-Cell Immunotherapy Market Deals Landscape
7 T-Cell Immunotherapy Raw Materials and Cost Structure Analysis
-
7.1 T-Cell Immunotherapy Key Raw Materials
-
7.2 T-Cell Immunotherapy Price Trend of Key Raw Materials
-
7.3 T-Cell Immunotherapy Key Suppliers of Raw Materials
-
7.4 T-Cell Immunotherapy Market Concentration Rate of Raw Materials
-
7.5 T-Cell Immunotherapy Cost Structure Analysis
-
7.5.1 T-Cell Immunotherapy Raw Materials Analysis
-
7.5.2 T-Cell Immunotherapy Labor Cost Analysis
-
7.5.3 T-Cell Immunotherapy Manufacturing Expenses Analysis
8 Global T-Cell Immunotherapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global T-Cell Immunotherapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global T-Cell Immunotherapy Export by Region (Top 10 Countries) (2017-2028)
9 Global T-Cell Immunotherapy Market Outlook by Types and Applications to 2022
-
9.1 Global T-Cell Immunotherapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CAR-T Consumption and Growth Rate (2017-2022)
-
9.1.2 Global TCR Consumption and Growth Rate (2017-2022)
-
9.1.3 Global TIL Therapies Consumption and Growth Rate (2017-2022)
-
9.2 Global T-Cell Immunotherapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Stomach Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Esophagus Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise T-Cell Immunotherapy Market Analysis and Outlook till 2022
-
10.1 Global T-Cell Immunotherapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States T-Cell Immunotherapy Consumption (2017-2022)
-
10.2.2 Canada T-Cell Immunotherapy Consumption (2017-2022)
-
10.2.3 Mexico T-Cell Immunotherapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.2 UK T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.3 Spain T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.4 Belgium T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.5 France T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.6 Italy T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.7 Denmark T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.8 Finland T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.9 Norway T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.10 Sweden T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.11 Poland T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.12 Russia T-Cell Immunotherapy Consumption (2017-2022)
-
10.3.13 Turkey T-Cell Immunotherapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.2 Japan T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.3 India T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.4 South Korea T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.5 Pakistan T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.6 Bangladesh T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.7 Indonesia T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.8 Thailand T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.9 Singapore T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.10 Malaysia T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.11 Philippines T-Cell Immunotherapy Consumption (2017-2022)
-
10.4.12 Vietnam T-Cell Immunotherapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.2 Colombia T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.3 Chile T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.4 Argentina T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.5 Venezuela T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.6 Peru T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.7 Puerto Rico T-Cell Immunotherapy Consumption (2017-2022)
-
10.5.8 Ecuador T-Cell Immunotherapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.2 Kuwait T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.3 Oman T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.4 Qatar T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia T-Cell Immunotherapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates T-Cell Immunotherapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria T-Cell Immunotherapy Consumption (2017-2022)
-
10.7.2 South Africa T-Cell Immunotherapy Consumption (2017-2022)
-
10.7.3 Egypt T-Cell Immunotherapy Consumption (2017-2022)
-
10.7.4 Algeria T-Cell Immunotherapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia T-Cell Immunotherapy Consumption (2017-2022)
-
10.8.2 New Zealand T-Cell Immunotherapy Consumption (2017-2022)
11 Global T-Cell Immunotherapy Competitive Analysis
-
11.1 Novartis
-
11.1.1 Novartis Company Details
-
11.1.2 Novartis T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Novartis T-Cell Immunotherapy Main Business and Markets Served
-
11.1.4 Novartis T-Cell Immunotherapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Takara Bio
-
11.2.1 Takara Bio Company Details
-
11.2.2 Takara Bio T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Takara Bio T-Cell Immunotherapy Main Business and Markets Served
-
11.2.4 Takara Bio T-Cell Immunotherapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Kite Pharma
-
11.3.1 Kite Pharma Company Details
-
11.3.2 Kite Pharma T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Kite Pharma T-Cell Immunotherapy Main Business and Markets Served
-
11.3.4 Kite Pharma T-Cell Immunotherapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Unum Therapeutics
-
11.4.1 Unum Therapeutics Company Details
-
11.4.2 Unum Therapeutics T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Unum Therapeutics T-Cell Immunotherapy Main Business and Markets Served
-
11.4.4 Unum Therapeutics T-Cell Immunotherapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Juno Therapeutics
-
11.5.1 Juno Therapeutics Company Details
-
11.5.2 Juno Therapeutics T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Juno Therapeutics T-Cell Immunotherapy Main Business and Markets Served
-
11.5.4 Juno Therapeutics T-Cell Immunotherapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Cellectis
-
11.6.1 Cellectis Company Details
-
11.6.2 Cellectis T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Cellectis T-Cell Immunotherapy Main Business and Markets Served
-
11.6.4 Cellectis T-Cell Immunotherapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Adaptimmune
-
11.7.1 Adaptimmune Company Details
-
11.7.2 Adaptimmune T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Adaptimmune T-Cell Immunotherapy Main Business and Markets Served
-
11.7.4 Adaptimmune T-Cell Immunotherapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Altor Bioscience Corporation
-
11.8.1 Altor Bioscience Corporation Company Details
-
11.8.2 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Altor Bioscience Corporation T-Cell Immunotherapy Main Business and Markets Served
-
11.8.4 Altor Bioscience Corporation T-Cell Immunotherapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
12 Global T-Cell Immunotherapy Market Outlook by Types and Applications to 2028
-
12.1 Global T-Cell Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global CAR-T Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global TCR Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global TIL Therapies Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global T-Cell Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Stomach Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Esophagus Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise T-Cell Immunotherapy Market Analysis and Outlook to 2028
-
13.1 Global T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.2.2 Canada T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.2 UK T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.3 Spain T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.5 France T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.6 Italy T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.8 Finland T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.9 Norway T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.11 Poland T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.12 Russia T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.2 Japan T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.3 India T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.3 Chile T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.6 Peru T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.3 Oman T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand T-Cell Immunotherapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of T-Cell Immunotherapy
-
Figure of T-Cell Immunotherapy Picture
-
Table Global T-Cell Immunotherapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global T-Cell Immunotherapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global CAR-T Consumption and Growth Rate (2017-2022)
-
Figure Global TCR Consumption and Growth Rate (2017-2022)
-
Figure Global TIL Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Stomach Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Esophagus Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Table North America T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure United States T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Canada T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Europe T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Germany T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure UK T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Spain T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure France T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Italy T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Finland T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Norway T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Poland T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Russia T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table APAC T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure China T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Japan T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure India T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table South America T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Brazil T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Chile T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Peru T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table GCC T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Bahrain T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Oman T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Africa T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Nigeria T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Oceania T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure Australia T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Novartis Company Details
-
Table Novartis T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis T-Cell Immunotherapy Main Business and Markets Served
-
Table Novartis T-Cell Immunotherapy Product Portfolio
-
Table Takara Bio Company Details
-
Table Takara Bio T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takara Bio T-Cell Immunotherapy Main Business and Markets Served
-
Table Takara Bio T-Cell Immunotherapy Product Portfolio
-
Table Kite Pharma Company Details
-
Table Kite Pharma T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kite Pharma T-Cell Immunotherapy Main Business and Markets Served
-
Table Kite Pharma T-Cell Immunotherapy Product Portfolio
-
Table Unum Therapeutics Company Details
-
Table Unum Therapeutics T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Unum Therapeutics T-Cell Immunotherapy Main Business and Markets Served
-
Table Unum Therapeutics T-Cell Immunotherapy Product Portfolio
-
Table Juno Therapeutics Company Details
-
Table Juno Therapeutics T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics T-Cell Immunotherapy Main Business and Markets Served
-
Table Juno Therapeutics T-Cell Immunotherapy Product Portfolio
-
Table Cellectis Company Details
-
Table Cellectis T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellectis T-Cell Immunotherapy Main Business and Markets Served
-
Table Cellectis T-Cell Immunotherapy Product Portfolio
-
Table Adaptimmune Company Details
-
Table Adaptimmune T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adaptimmune T-Cell Immunotherapy Main Business and Markets Served
-
Table Adaptimmune T-Cell Immunotherapy Product Portfolio
-
Table Altor Bioscience Corporation Company Details
-
Table Altor Bioscience Corporation T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Altor Bioscience Corporation T-Cell Immunotherapy Main Business and Markets Served
-
Table Altor Bioscience Corporation T-Cell Immunotherapy Product Portfolio
-
Figure Global CAR-T Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TCR Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TIL Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stomach Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Esophagus Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Table North America T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure United States T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Germany T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure China T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure Australia T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
